Pharmaceutical

Private equity deals in pharmaceutical in China increased in Q2 2023

In China pharmaceutical industry, there were 6 private equity deals announced in Q2 2023, worth a total value of $1.2bn, according to GlobalData's Deals Database.

Jul 31, 2023 - 20:00
In China pharmaceutical industry, there were 6 private equity deals announced in Q2 2023, worth a total value of $1.2bn, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

STAT+: Mitch McConnell’s abrupt episode has an important public health takeaway

Next Article

Private equity deals in pharmaceutical in Germany increased in Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Cipla sees highest patent filings and grants during Sep...

Dec 10, 2023

STAT+: After a lull, the pace of FDA authorization of AI-enabled medical devices is rising

STAT+: After a lull, the pace of FDA authorization of A...

Oct 20, 2023

CTX-310 by CRISPR Therapeutics for Hypertriglyceridemia...

Jul 6, 2024